Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gowen

Showing results (621-630 of 681) with videos related to

Pageof 69
Sort By:
Antiviral Research|July 26, 2023
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023Jessica R Spengler, Kara Carter, Leen Delang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Cancer Epidemiology|February 15, 2025
Addressing the cervical cancer burden in the Rio Grande Valley of Texas through a multi-component program to improve screening and diagnostic follow-up: A retrospective cohort studyMelissa Lopez Varon, Mila Pontremoli Salcedo, Bryan Fellman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2005
Resistance to diet-induced obesity in mice globally overexpressing OGH/GPB5Lynn E Macdonald, Katherine E Wortley, Lori C Gowen, et al.
Elife|November 14, 2015
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cellsBenjamin G Gowen, Bryan Chim, Caleb D Marceau, et al.
Plos Pathogens|December 22, 2018
A potent Lassa virus antiviral targets an arenavirus virulence determinantIkenna G Madu, Megan Files, Dima N Gharaibeh, et al.
Journal of Public Health Management and Practice : JPHMP|June 23, 2023
A Comprehensive Program to Improve Treatment of Precancerous Cervical Lesions in the Rio Grande Valley of TexasMelissa Varon, Mila Pontremoli Salcedo, Bryan Fellman, et al.
Bone|September 12, 2006
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeysS Kumar, L Dare, J A Vasko-Moser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2016
Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic TargetEvgeny Yakirevich, Murray B Resnick, Shamlal Mangray, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 21, 2005
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculatureTomomi Kamba, Betty Y Y Tam, Hiroya Hashizume, et al.
Pageof 69

Showing results (621-630 of 681) with videos related to

Sort By:
Pageof 69
Antiviral Research|July 26, 2023
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023Jessica R Spengler, Kara Carter, Leen Delang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Cancer Epidemiology|February 15, 2025
Addressing the cervical cancer burden in the Rio Grande Valley of Texas through a multi-component program to improve screening and diagnostic follow-up: A retrospective cohort studyMelissa Lopez Varon, Mila Pontremoli Salcedo, Bryan Fellman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2005
Resistance to diet-induced obesity in mice globally overexpressing OGH/GPB5Lynn E Macdonald, Katherine E Wortley, Lori C Gowen, et al.
Elife|November 14, 2015
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cellsBenjamin G Gowen, Bryan Chim, Caleb D Marceau, et al.
Plos Pathogens|December 22, 2018
A potent Lassa virus antiviral targets an arenavirus virulence determinantIkenna G Madu, Megan Files, Dima N Gharaibeh, et al.
Journal of Public Health Management and Practice : JPHMP|June 23, 2023
A Comprehensive Program to Improve Treatment of Precancerous Cervical Lesions in the Rio Grande Valley of TexasMelissa Varon, Mila Pontremoli Salcedo, Bryan Fellman, et al.
Bone|September 12, 2006
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeysS Kumar, L Dare, J A Vasko-Moser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2016
Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic TargetEvgeny Yakirevich, Murray B Resnick, Shamlal Mangray, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 21, 2005
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculatureTomomi Kamba, Betty Y Y Tam, Hiroya Hashizume, et al.
Pageof 69